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density, end myocyto width was measured with 400x on 1 Hm slides by light 
microscopy, Intorstlttnnl tissue w(]s expressed as % of total area, 
Results: The stonosis reduced moan LAD flow from 0,90 ± 0.12 to 0,55 
~: 0.12 ml/min/g nnd wall thickening from 38 :~- 3% to 10 "J: 6%. Alter 4 weeks 
of repeduston, wnnll thickening in HM reoovered to 28 ± 4%, Results el the 
mlcrosooplo study am presented In the t81ble: 
Conlrol Day 7 of 6tenonl~ Roporfu~lon 
Myocyta Den,lty 57 ;t 1 45 ~; 4' ~14 ± 3 
Myocyl~ wldlh (urn) 17,7 ~ 0,3 2P..2 :t~ P.,0' 182 ~ (],0 
Intcr~llti~l¢ontl~nt (%) 1~,0 ~: 0,2 17,8 ~ 2,3' t6,t .t, 1,4' 
'P ,~ 0,01 Compared to b~aol~ne 
Concluf~lon~: Reped(]slon of hlbern81ting my(]oardigm for 4 weeks restores 
myecyte number n(]mss th(] LV we111, Indlc81tlng recov(]ry in the armngomect 
ot myo(~yto bgndlee~ 81nd pmllal regression of rnyuwte hypedrophy, 
~ Increased Level t  and Thrombln  Cytok lne 
Generat ion In 8table Angina are Radu©e¢l by 
Aspir in,  A Randemlud ,Cont ro l led ,  Cro#l ,ovet  
'rdal 
I, Ikonomidls, F, Andmottl ~ , C, St8110nsdla, C, Pit,ayes, E, Eoonomou, 
P, "l'ogtogz818, E Nihoyannapo(]l(]s ~ , Ca~tology Ippocr~fian Hopif~l, Ath(]ns, 
GroPe: fH81mmot~mlfh Ho,~pifal Lonclon, UK 
~ckm¢~nd: Ro~enlty, the redu~tio, o! th(] ask tar myooardi811 Intamtion by as- 
pirin (ASA) h~s b(](]n attrlbuteed to its 81ntilnll~mm81tory p op(idle81 even when 
admlntst(]red P.f low doses. M~cmplt819(] colony 811tmu181ting factor (MCSF) 
causes m81crOphBg(]/monocyto acttv81tlon 81nd thus, release of vasoaotlve 
e(]bM81n~ms, intedeuklns lb (ILlb) and 6 ilL0) end tissue factor. Our aim was 
to tnvestlgst(] whether high cytoktne levi]Is 81nd Incm81sed thrombln goner. 
allen a) occur In stable angina (SA) b) are re181ted to transient myocardial 
tschaemla and c) 81m reduced by aspirin 
M~thocls: We measured prothrombln fragments (PF1 + 2, nmole/I) MCSF, 
ILl b, tL8 (pg/ml) plosmrt levels in 60 patients with SA and in 2 t he811thy centers 
by ELIS~, S81mplas were obtained at the 81nd o! a 46 h Halter monitoring (HM), 
All patients had anglogmphlcalty documented dlso81se and positive exemtso 
test. Fourty patients h81d isch81emla in HM and were randomly treated with 
ASA 300 rag, o.d, or placebo for 3 weeks in a double blind, erase-over trial. 
Melee(Is: PF1 + 2, MCSF, and IL6 were Increased in patients with SA 
comp81md to controls (table, p < 0,01), Analysis el variance showed that 
MCSF end ILlb increased according 1o the number of diseased (1-2-3) 
vessels (p - 0.05), Only MCSF was higher in patients with lschaemia in HM 
than those without (1124 ~ 651 vs 528 ~ 417, p -: 0.01). Although, PF1 + 2 
and cytokine levels wore decreasod by ASA (181bte, p - 0.05), they remained 
higher than those in controls (p ~ 0,05) 
~A ASA CONTROLS p 
PF1 * 2 226 t t 8 1 73 't 1 2 0.93 .t 0,5 -0.01 
MCSF 1076 t ~,13 950 t .567 479 t 207 .0.05 
IL0 4.2 ~: 1 3 3.5 "t 081 2.0 :t 0,9 • 0.05 
Conclusion: Elevated cytokine and PF1 + 2 plasma levels in SA sug- 
gest the presence of enhanced inflammatory activity and incre81sed threm- 
bin generation. Only MCSF was related to both extent of disease and 
daily life ischaemia. Reduction of the above factors by ASA may repre- 
sent an additional mechanism of its therapeutic action in coronanj artery 
disease. 
I 1004-136J  Estrogen and Progesterone Decrease Lipid 
Loading In Human Female Macrophages  
Jane A. McCrohen, Wondy Jessup, Shirley Nakhla, David S. Celermajer. 
The Heart Research Institute, Sydney, Australia 
Bac.=(grounc/: BaSed on the lower incidence of athereselerosis in females, we 
hypothesized that estrogen and progesterone may reduce lipid-loading in 
human macrophages (ie. foam cell formation). 
Methods: Monocytes from healthy female donors (n = 5) were plated out 
in phenol-red free RPMI and allowed to differentiate into macrophagos over 
10 days. Cells were treated from days 2-10 with either control media, 17 
-estradid (2 nM and 200 nM) ~ the estrogen receptor antagonist ICI 182 
780, diothylstilbestrol (DES, non-stereidal estrogen), 17~-estradiol (17.¢.E, 
inactive stereoisomer) or progesterone 10 nM. Lipid-loading was assessed 
by HPLC after a 48 hr incubation (days 8-10) with acetylated LDL in lipopro. 
tein-deficient human serum. Triplicate wells were used for each condition, in 
each experiment. 
Results: Macrophages treated with 17/~.estradiol showed a significant 
dose-related reduction in cholesterol ester formation vs controls (88 ± 12% 
and 78 ± 14% for 2nM end 200aM ostradiol respectively vs 100 ± 5%. 
p = 0.04 by ANOVA). Them was a similar trend in the levels of free and 
total cholesterol (p : 0,06). These effects worn not blocked by ICI 182 780, 
Progesterone alone (10 nM) was also associated with a marked redu(]tion in 
choloeter01 ester loading (16 ± 5%, p .~ 0,00 ;). In ooantrast, DES end 17..E 
did not reduce lipid loading, E81trogen exposure In male mecmphegea (n = 
4), showed no algnlfloant effect (89 :E 13%). 
Conclusion: 17p-estradlo181nd progesterone reduce lipid loading in human 
f(]m8110 mecrophegoa, consistent with en etheropretective effect, 
Coronary $tenUng: Procedural 
Considerations 
Sunday, March 29, 1998, 5:00 p,m.-7:00 p.rn. 
Georgia World Congress Center, West Exhibit Hall Level 
Presentation Hour: 5:00 p,m,-7:00 p,m, 
• Improved Proe~lura l  Resu l ts  o f  Coronary  
........ 8 tent ing With Focal  Ba l loon  "Overoxpane lon"  -
Fine! Core Lab Analysis From the Prospect ive,  
Mult leenfer  OSTI-RA ~ la l  
G.W, Stone. S, Kiosk, S. B81iloy, I'. Sanbom, D. R(]berts, A Oshim~, 
E, Aldelman, P. Yeck, IF. St. Gck!l, T.J. Linnemeier. El Camino ~ra l ,  
Mountain Vmw, CA, USA 
The pnman/deferminant el 181re Outcome following corona w stealing m the 
rain, slant die+ (MSD) or rain. stant area (MSA) achieved. Slant expansion 
continues to increase as press(ire is raised from 12 to 18 arm. To study 
whether luminal dimensions can be safely further increased by using over. 
sized t)alloorls at high pressure, Patroaz-Schatz steals were implanted at 18 
arm. in 143 COnSecutive Isns in 120 pts at 7 centers. IVUS was pedonned. 
and it ~0.7 mrs of vessel remodeling was present at the lesion (external 
elastic membrane die. • ref. segment lumen die. ~:0.7 mm). the st0nt was 
further expanded with a balloon ._-0.5 mm larger at 16 atm. To minimize 
edge dissections found in prior trials of aggressive stealing, a novel focally 
expanding balloon was used which grows 0.5 mm larger centrally (within 
the slant) than outside the stent (the CVD FACT'=). QCA and IVUS were 
performed pro. pest standard stenting, and post focal stenting, and analyzed 
at independent core labs (Stanford). 
Results: By QCA, the baseline mean tel. dia. was 3.02 ± 0.48 mm and 
MLD was 1.10 ± 0.53 mm Remodeling was present to permit focal stent 
"overexpanston" in 120 of 143 lens (84%). 
slandaz'd slanting local slanting p value 
Mezzo balloon dta 336 ~ 037 3 87 ~ O 37 - O 0001 
Bai)oon-afto~ r~tlo 112 ~: (]17 1.33 -~ 020 - OOOOt 
MSD (turn). QCA 2.78 J: 0.43 2.93 x 0.44 -.0 0001 
MSO (rnm). IVUS 2.77 i Q39 2(]5 ~ 0.38 .00001 
MSA (rnm ~') - IVUS 7.29 ± 1 89 8.22 t 1 90 .00001 
By QCA, dissections were present at 4 stent edges after standard balloons 
and 1 slant edge alter focal upsizing, No pedorations, subacute thromboses 
or major ischomic complications occun'ed. 
Conclusions: Balloons traditionally considered ovemized, applied focally 
within the slant borders, may safely be used in the majority of lesions, and 
result in improved luminal dimensions. 
• I s  High Pressure Inflation Necessary for Optimal 
Stent ing? 
S. Elezi, A. Kastrati. J. Pache. J. Dirschinger, A. Sch~mig. 1. MedJzinische 
Klinik & Deutsches Herzzentrum, TU Munchen, Germany 
High pressure inflation after comnan/stent placement has been employed 
to achieve optimal stent deployment. However, it is not clear whether this 
is due to more radial tome generated by high pressure inflation o= simply 
by bigger balloon size. Quantitative angiograph¢c analysis we performed 
on 2724 lesions (2096 patients). The adequacy of stent deployment was 
based on pe, :eat diameter .~tenosis (DS) immediately after stent placement. 
Balloon to vessel ratio (BRD) and balloon pressure (BP) correlated with DS, 
but there was a much stronger correlation for BRD (r = -0.63 vs. r = -0.21, 
p < 0.001). When both BRD and BP were entered in a multivariate stepwise 
linear regression analysis (DS as a outcome variable), together with other 
factors, a significant independent role could be documented only for BRD (/~ 
= -0.641, p < 0.001). 
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Con¢tu~Km: High beltoo~ prossum m~y not be imlx~t~nt as tong a~ an 
ad~uato bet(non In vessel ratio is m,~ntained, This data indicates also thai 
balloon to veseel ratio iS cr~ial for adequate alan( dep!oymem, 
. . . . . . . . .  !01; ¢omnaly  8 t ln t  P!~nL  8-Mo~th Cllnlca! 
and Angk)gmphi~ Rnu l ts  From m Randond led  
Multleent~r Trial !
J, Dtrechi~f, J. Hausleitee, H. S(~t~=n, W. Gtehd ~ , H Wafter, J, P~:he. 
A. Kastrati, S, Elezl. A W~r .  M. Hadam~tzky, 13. Boek~ege~ I ,
G, S tmn~l /~ ~ ~ HeF~zentrum & Kttnikl~re chrs der 
Isa~ ~ LIr~emM~ &~niCh, ~ ;  ~ Kft~kunl Gn3~hadern, 
L~M<~z~.~ans.UnNers~at. Mim~ch. German~ 
gaekg~t  The m~pa~ cA ~ t~eoon pressure fo~ slant p~eme~t 
chn~al and a n g ~  ~ ~s st~ll under d~scuss~on, 
Me~o0~ From May 96-May 97, 11;~6 p~tmnts were ~ze¢ l  to eff~er 
"high pressure" implantati0n (575 intef~Bfllions m ILK3 le~;  b.a]kx~l I:~I~S- 
sure 16.7 ± 2.3 alto) o¢ "nom~ pressure" imptsntalmn (572 intarcentmns 
in 843 lesiorts; balto~l pressure 11.1 ± 2.3 arm). Per protocol, only patients 
wdh caldiogeni¢ shock or mechanmal ventilation pnor tO the intervention, 
patients which already had been slanted in the same vessel and pat~W~tS 
wtthe~ut consent were e~-'luded. 
~ :  Cot~te  4-week ~-up  data are currently avaulable in 98_4%. 
No s~j~ficant d~em,n~=s in major adveme cardiac events (MACE) or lbe rate 
ol stem thrembos=s ~ seen between tha two treatment greups (over~l 
MACE rate 3.8%). As ol today. 750 patients were elig~bte for 6-mOrlth 1of 
k~,~Jp (i.e. portents wth successful slanting before Janua~ 31. 1997 and 
without MACE at 4 weeks) which has been completed in 85% of eligible 
C, onctuseons: These preliminary data suggest that early results are not 
s~gnifecantty different. A complete clinical and angiographic 6-month follow-up 
w.ll be available. 
1•5-8• Does Systematic High Pressure Deployment Improve Clinical Outcome After Palmaz-Schatz 
Coronary Slant  Implantat ion? 
v Strattev. B. Chevalier. B. G1atL P. Guyon. 1". Royer. Centre C.at~olog~que 
du Nord. Sa~nt.DenLs, France 
Previous reports emphasized the intravascular echegraphy benefit of sys- 
tematic high pressure (HP) stent deployment but its clinK::al benefit es still 
questionable. Since 01/94. we systematically used HP then, from 05/95 to 
17J96, we decided to change our policy using an 8 to 12 attn. pressure 
and only more pressure in case of residual balloon indentation or stenosis 
_~ 10%. We compared all consecutive Palmaz-Schatz stent implantations dur- 
ing these two time peneds. Both groups received a ticlop~dine/aspihn drug 
regimen. In HP group (N = 337 pts, 88% of stents with pressure _> 15 aim ) 
and regular pressure group (RP, N = 305 pts. 88% of stents w~th a pressure 
< 15 aim.), clinical data were similar but a higher rate of acute MI PTCA m R P 
group. Angiographic data analysis revealed a higher rate of LAD PTCA and 
B2/C type lesion in RP pts. Procedural data and stent indication were similar 
in both groups, except pressure. In-hospital (InH) and 1 year follow-up (Fup) 
clinical results were (MACE = Death, O MI, CABG): 
HP RP p 
Clinical success (%) 97 98 NS 
Stent hrombosis (%) 1.2 1.3 NS 
InH MACE (%) 3 2 NS 
Fup TLR (%) 13 108 NS 
Fup MACE (%) 8 43 0.07 
Event-tree survival rate (%): 77.4 83.8 0 05 
Thus, in our experience, a systematic use of HP Palmaz-Schatz stent 
deployment is not beneliciaL 
1005: ,8~ COat Impact of High Pmuum Inflation= and 
Therapy With A Ip l r ln  and Ti¢lopl¢ltne After 
Coronary  Stentlng 
J ~tanco, WS Wointrau~), Y. Shah, H. Chmnos, O. McA~ams, N Chronos, 
Z,M~B, Ghazzal, S,B. King, IlL £mory Univemi~ AKan~, GA, U~4 
Post.stertt high pressure infl~t~tl~ (HPI) with (tsptnn and ticlop~rle (AT) (~= 
cm~e ~ubecut~ thtombesis ~nd vascular compl¢atto~ (VC). To ¢let~i~_ 
tt"~ir i~flu~nce on proc~ml  a~ hoepltal corn, P~rCA w~ mint 
m~nt for i~m-beilo~ ifl(~.att(Xt~ (elect~,_, ~ubepl~mal ~ P0~t-belloo~) m
663 pati~rtt~ (719 I(~!~lS) were Im4ewed; the initial 335 patteMs 
(C) ~ no, HPI and ~ ~ ~ l~, t~ ~ HPI al~ AT, 
Although the ~ 01 t~v~ cuffefllly used for non.l:~!out 8te~ placement 
r~ slightly higher, total hospffal COSTS ha~ ~ reckh'.ed with HPI and AT, 
due to ~h0rter hO~{t~l ~y,  tess in -~ la!  CABG and less VC (~) ,  
NO HPt * C IdP| ~ AT P Va~ttm 
E~. Pie (%t ~.3 (55) 1~3 (50) n~, 
S~t~plzmai Res-~tt |%~1 152 {45) t 35 (41 ) na 
IVUS 1%) ~ (a.4) ~711~5) - 0.0COt 
IrvH~pr~al CABG (%) 13 (3 el 2 (061 0.005 
Vascuia~ Compt~..,ltmns ~I (183) 1514 8) -~ 0 t3001 
Dea~ 6 ItS) 2 tO.6) 0 29 
L~of  5Ia~/((:ta~) 85 ¢ 4 7' 2 4 ± 51 ~00001 
Dev¢a Cu'st IS) 27'~ ~- 1003 3391 ~: 1375 - 0000t 
Total Ho~ffal Cos1 ($) 12.488 z 6404 8752 ± 3795 • 0 000t 
H~Jh pressure inltahen with am,n  and liclo~dtne have clear;y improved 
patient cam; oulc0me has n,n~mved ~ while hospital costs have 
fallen. 
~ A~mssment  of  Optimal Stent Implantation Using 
Computer ized I=~mu~Vatume Curves 
AT  Weiss, Y Rozenm~n, M• Mossen, I. Katz, C. Lotan, H. Nassar, 
MS. Gotsman. Hadassah Ho~,  Jerusa~m, Israel 
Optimal slant deployment (D) is crt~al to ensure short- and long-term po- 
tency ~d may require add[t~3nal IVUS, an [nvaslve and expensive tool 
P~'sum vatume curves (PVC) of balloon inflation denved from our Com- 
outerized Aulom~c PrL='~ure ~n~m and Im~lantahon []~nr.~ (CAPSID), 
reflecl ~ance  to stent opening. We calculated the area ~dex betv..een 
the PVC m~de file slent (restrained inflation) and the PVC in air (unrestrained 
inflation). This area i~ex that reflects the reslram imposed by the stem to 
balloon inflation, correlated with WUS-MUSIC criteria for stem D: optimal D 
(group t. 5 patients), ber~itise D (group 2, 6 pat3ents) and poor D (group 3, 
4 patients): 
IVUS Group 1 Group 2 Grotto 3 
IFVC area- 7.6 ¢ 45" 33 3 ± 12 1" 805 ± 483" 
• p ~ 0 05betweerlafl g ot.'ps." i~orrl~IizedlrlOell . t000 
In 10 patients in whom ang~ography suggested need for higher pressure 
ioflatlorls, the area index decreased from 72.3 ¢ 3.4 to 26.9 ± 9.1. Ten 
patients who did not require additmnal inflation had an average area index of 
19.9 ± 8.5 and a good outcome. 
We Cmc/ude: CAPSID PVC are a good guide for stem D and the need 
for further inflatmn, with good correlation to IVUS assessment. 
- 1 ~  Transradial for ad hoc Coronary Approach 
Interventions: Procedural Results and Vascmar 
Complicat ions 
G.R. Barbeau. O. Glee(an, L. Roy, S Plan(e, C. Juneau, G. Pmulx. 
M .M Lanv~m. Instltut de cardiolo~e de QuL~bec. Cansda 
Background: Percutaneous transradial approach (PTRA) has the potential 
for low vascular complications, ~mmedi-3te goat-procedural sheath removal 
and early ambulation This senes evaluate the safety and efficacy ot this 
technique for the first 3053 consecutwe procedures (prec.) dunng teaming 
curves of 6 interventional cardiologists. 
Results: Between July 94 and June 97. PTRA was attempted in 3053 pro: 
in 2597 patients (pts), 73% mate, with a functional radial arterial arch. In 260 
pts. PTRA was performed up to 5 times, days to months later. Mean age was 
60 years (17-94) with a w~de range of weight (33-152 kg) and height (1.1-2.0 
m). Coronary angiography was performed in 1560 pts (same-day d~'harge 
in 58%). ad hoc (?~3%) or elective angioptasty was performed in 1493 pts 
including coronary stenting in 670 pts. PTRA was not possible in 295 proc. 
(9.6%) Unsuooe~ful rndial 2~oP/canulafion (208), anqtnm ca vanation (49), 
